Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
HOWL
#3650
Werewolf Therapeutics, Inc. Common Stock
0.6
0
-1.64%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
-1.64%
Changement Mensuel
-11.76%
Evolution sur 6 mois
-55.88%
Changement Annuel
-49.15%
Clôture Précédente
0.6
1
Open
0.6
0
Bid
Ask
Low
0.6
0
High
0.6
0
Volume
3
Marchés
Actions des Marchés US
Soins de Santé
HOWL
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
27.65 M
35.28 M
42.74 M
44.83 M
—
Valuation ratios
Enterprise value
171.82 M
-56.99 M
63.96 M
-44.65 M
-90.9 M
Price to earnings ratio
-1.09
-1.1
-4.42
-0.91
-3.42
Price to sales ratio
—
73.96
105.89
163.1
—
Price to cash flow ratio
5.13
1.46
5.07
1.16
4.06
Price to book ratio
1.44
0.48
1.49
0.88
1.64
Enterprise value to EBITDA ratio
—
—
—
—
—
Profitability ratios
Return on assets %
-0.28
-0.34
-0.21
-0.56
-0.73
Return on equity %
-0.33
-0.44
-0.34
-0.96
-1.58
Return on invested capital %
-1 040.55
-935.92
-436.07
-964.14
—
Gross margin %
—
100
100
100
—
Operating margin %
—
-7 007
-2 593.02
-18.49 K
—
EBITDA margin %
—
—
—
—
—
Net margin %
—
-6 726.25
-2 392.32
-17.72 K
—
Liquidity ratios
Quick ratio
—
—
—
—
—
Current ratio
13.56
5.84
7.14
7.45
24.72
Inventory turnover
—
—
—
—
—
Asset turnover
—
0
0.01
0
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
—
—
0.19
0.21
0.99
Long term debt to total equity ratio
—
—
0.29
0.36
2.15
Per share metrics
Operating cash flow per share
-2.32
-1.41
-0.91
-1.28
-1.42
EBIT per share
—
—
—
—
—
EBITDA per share
—
—
—
—
—
Total debt per share
—
—
—
—
—
Cash per share
8.53
4.48
3.77
2.53
7.76
Net current asset value per share
8.73
4.86
3.88
2.58
7.98
Tangible book value per share
8.28
4.24
3.12
1.67
4.53
Working capital per share
8.08
4.03
3.34
2.23
6.65
Book value per share
8.28
4.24
3.12
1.67
4.53
Nouvelles
Werewolf Therapeutics explore une vente et des alternatives stratégiques
Werewolf Therapeutics explores sale and strategic alternatives
Le titre de Werewolf Therapeutics chute après l’annonce d’une réduction de 64% des effectifs
Werewolf Therapeutics stock falls after announcing 64% workforce reduction
Werewolf Therapeutics reçoit un avis du Nasdaq pour non-conformité du prix minimum
Werewolf Therapeutics receives Nasdaq notice for minimum bid price deficiency
Luke Evnin, directeur de Werewolf Therapeutics, vend des actions HOWL pour 20.942€
Evnin Luke, Werewolf Therapeutics director, sells $20,942 in Howl stock
Evnin Luke vend des actions de Werewolf Therapeutics (HOWL) pour 53.533€
Evnin Luke sells Werewolf Therapeutics (HOWL) shares for $53,533
Luke Evnin vend des actions de Werewolf Therapeutics (HOWL) pour 45.882$
Evnin Luke sells Werewolf Therapeutics (HOWL) stock for $45,882